Elevated hepatic fatty acid elongase-5 activity corrects dietary fat-induced hyperglycemia in obese C57BL/6J mice

Journal of Lipid Research

Volumn 51, Issue 9, 2010, Pages 2642-2654

  Tripathy, Sasmita ^a   Torres Gonzalez, Moises ^a   Jump, Donald B ^a  

^a OREGON STATE UNIVERSITY   (United States)

Author keywords

Diabetes; Elovl5; Fatty liver; FoxO1; Gluconeogenesis; PGC1

Indexed keywords

FATTY ACID; FATTY ACID ELONGASE 5; GLUCOSE; GLUCOSE 6 PHOSPHATE; INSULIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); PHOSPHOPROTEIN PHOSPHATASE 2A; PROTEIN KINASE B; TRANSCRIPTION FACTOR FKHR; UNCLASSIFIED DRUG;

ADENOVIRUS INFECTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DIETARY INTAKE; ENZYME ACTIVATION; ENZYME ACTIVITY; FAT INTAKE; FATTY ACID ANALYSIS; FOOD INTAKE; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HOMEOSTASIS; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIVER; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ACETYLTRANSFERASES; ANIMALS; BLOOD GLUCOSE; CHOLESTEROL; DIET; DIETARY FATS; FATTY ACIDS; GENE EXPRESSION REGULATION; GLUCONEOGENESIS; GLUCOSE TOLERANCE TEST; HUMANS; HYPERGLYCEMIA; INSULIN; ISOENZYMES; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, OBESE; MOLECULAR SEQUENCE DATA; SIGNAL TRANSDUCTION; TRIGLYCERIDES;

EID: 77956838705     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M006080     Document Type: Article

References (54)

1. Cinti, D. L., L. Cook, M. N. Nagi, and S. K. Suneja. 1992. The fatty acid chain elongation system of mammalian endoplasmic reticulum. Prog. Lipid Res. 31: 1-51.
2. Jakobsson, A., R. Westerberg, and A. Jacobsson. 2006. Fatty acid elongases in mammals: their regulation and role in metabolism. Prog. Lipid Res. 45: 237-249.
3. Leonard, A. E., S. L. Pereira, H. Sprecher, and Y. S. Huang. 2004. Elongation of long-chain fatty acids. Prog. Lipid Res. 43: 36-54.
4. Denic, V., and J. S. Weissman. 2007. A molecular caliper mechanism for determining very long-chain fatty acid length. Cell. 130: 663-677.
5. Moon, Y. A., and J. D. Horton. 2003. Identification of two mammalian reductases involved in the two-carbon fatty acyl elongation cascade. J. Biol. Chem. 278: 7335-7343.
6. Cook, H. W. 1985. Fatty acid desaturation and chain elongation in eucaryotes. In Biochemistry of Lipids and Membranes. D. E. Vance and J. E. Vance, eds. Benjamin Cummings Publishing Co., Don Mill, ON. 181-212.
7. Wang, Y., D. Botolin, J. Xu, B. Christian, E. Mitchell, B. Jayaprakasam, M. G. Nair, J. M. Peters, J. V. Busik, L. K. Olson, et al. 2006. Regulation of hepatic fatty acid elongase and desaturase expression in diabetes and obesity. J. Lipid Res. 47: 2028-2041.
8. Wang, Y., D. Botolin, B. Christian, J. Busik, J. Xu, and D. B. Jump. 2005. Tissue-specific, nutritional, and developmental regulation of rat fatty acid elongases. J. Lipid Res. 46: 706-715.
9. Moon, Y. A., N. A. Shah, S. Mohapatra, J. A. Warrington, and J. D. Horton. 2001. Identification of a mammalian long chain fatty acyl elongase regulated by sterol regulatory element-binding proteins. J. Biol. Chem. 276: 45358-45366.
10. Wang, Y., M. Torres-Gonzalez, S. Tripathy, D. Botolin, B. Christian, and D. B. Jump. 2008. Elevated hepatic fatty acid elongase-5 activity affects multiple pathways controlling hepatic lipid and carbohydrate composition. J. Lipid Res. 49: 1538-1552.
11. Sprecher, H. 2000. Metabolism of highly unsaturated n-3 and n-6 fatty acids. Biochim. Biophys. Acta. 1486: 219-231.
12. Westerberg, R., J. E. Mansson, V. Golozoubova, I. G. Shabalina, E. C. Backlund, P. Tvrdik, K. Retterstol, M. R. Capecchi, and A. Jacobsson. 2006. ELOVL3 is an important component for early onset of lipid recruitment in brown adipose tissue. J. Biol. Chem. 281: 4958-4968.
13. Jump, D. B., D. Botolin, Y. Wang, J. Xu, O. Demeure, and B. Christian. 2008. Docosahexaenoic acid (DHA) and hepatic gene transcription. Chem. Phys. Lipids. 153: 3-13.
14. Jump, D. B. 2008. N-3 polyunsaturated fatty acid regulation of hepatic gene transcription. Curr. Opin. Lipidol. 19: 242-247.
15. Jump, D. B. 2004. Fatty acid regulation of gene transcription. Crit. Rev. Clin. Lab. Sci. 41: 41-78.
16. Matsuzaka, T., H. Shimano, N. Yahagi, T. Kato, A. Atsumi, T. Yamamoto, N. Inoue, M. Ishikawa, S. Okada, N. Ishigaki, et al. 2007. Crucial role of a long-chain fatty acid elongase, Elovl6, in obesity-induced insulin resistance. Nat. Med. 13: 1193-1202.
17. Moon, Y. A., R. E. Hammer, and J. D. Horton. 2008. Deletion of ELOVL5 leads to fatty liver through activation of SREBP-1c in mice. J. Lipid Res. 50: 412-423.
18. Yang, J., X. Kong, M. E. Martins-Santos, G. Aleman, E. Chaco, G. E. Liu, S. Y. Wu, D. Samols, P. Hakimi, C. M. Chiang, et al. 2009. Activation of SIRT1 by resveratrol represses transcription of the gene for the cytosolic form of phosphoenolpyruvate carboxykinase (GTP) by deacetylating hepatic nuclear factor 4alpha. J. Biol. Chem. 284: 27042-27053.
19. Rhee, J., Y. Inoue, J. C. Yoon, P. Puigserver, M. Fan, F. J. Gonzalez, and B. M. Spiegelman. 2003. Regulation of hepatic fasting response by PPARgamma coactivator-1alpha (PGC-1): requirement for hepatocyte nuclear factor 4alpha in gluconeogenesis. Proc. Natl. Acad. Sci. USA. 100: 4012-4017.
20. Zhang, W., S. Patil, B. Chauhan, S. Guo, D. R. Powell, J. Le, A. Klotsas, R. Matika, X. Xiao, R. Franks, et al. 2006. FoxO1 regulates multiple metabolic pathways in the liver: effects on gluconeogenic, glycolytic, and lipogenic gene expression. J. Biol. Chem. 281: 10105-10117.
21. Cassuto, H., K. Kochan, K. Chakravarty, H. Cohen, B. Blum, Y. Olswang, P. Hakimi, C. Xu, D. Massillon, R. W. Hanson, et al. 2005. Glucocorticoids regulate transcription of the gene for phosphoenolpyruvate carboxykinase in the liver via an extended glucocorticoid regulatory unit. J. Biol. Chem. 280: 33873-33884.
22. Koo, S. H., H. Satoh, S. Herzig, C. H. Lee, S. Hedrick, R. Kulkarni, R. M. Evans, J. Olefsky, and M. Montminy. 2004. PGC-1 promotes insulin resistance in liver through PPAR-alpha-dependent induction of TRB-3. Nat. Med. 10: 530-534.
23. Potthoff, M. J., T. Inagaki, S. Satapati, X. Ding, T. He, R. Goetz, M. Mohammadi, B. N. Finck, D. J. Mangelsdorf, S. A. Kliewer, et al. 2009. FGF21 induces PGC-1alpha and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response. Proc. Natl. Acad. Sci. USA. 106: 10853-10858.
24. Puigserver, P., J. Rhee, J. Donovan, C. J. Walkey, J. C. Yoon, F. Oriente, Y. Kitamura, J. Altomonte, H. Dong, D. Accili, et al. 2003. Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction. Nature. 423: 550-555.
25. Matsumoto, M., A. Pocai, L. Rossetti, R. A. Depinho, and D. Accili. 2007. Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor Foxo1 in liver. Cell Metab. 6: 208-216.
26. Aoki, M., H. Jiang, and P. K. Vogt. 2004. Proteasomal degradation of FoxO1 transcriptional regulator in cells transformed by P3K and Akt oncoproteins. Proc. Natl. Acad. Sci. USA. 101: 13613-13617.
27. Guo, S., G. Rena, S. Cichy, X. He, P. Cohen, and T. Unterman. 1999. Phosphorylation of serine 256 by protein kinase B disrupts transactivation by FKHR and mediates effects of insulin on insulin-like growth factor-binding protein-1 promoter activity through a conserved insulin response sequence. J. Biol. Chem. 274: 17184-17192.
28. An, J., D. M. Muoio, M. Shiota, Y. Fujimoto, G. W. Cline, G. I. Shulman, T. R. Koves, R. Stevens, D. Millington, and C. B. Newgard. 2004. Hepatic expression of malonyl CoA decarboxylase reverses muscle, liver and whole animal insulin resistance. Nat. Med. 10: 268-274.
29. Yoon, J. C., P. Puigserver, G. Chen, J. Donovan, Z. Wu, J. Rhee, G. Adelmant, J. Stafford, C. R. Kahn, D. K. Granner, et al. 2001. Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature. 413: 131-138.
30. Inagaki, T., P. Dutchak, G. Zhao, X. Ding, L. Gautron, V. Parameswara, Y. Li, R. Goetz, M. Mohammadi, V. Esser, et al. 2007. Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21. Cell Metab. 5: 415-425.
31. Raymer, B., M. Kavana, A. Price, B. Wang, L. Corcoran, R. Kulathila, J. Groarke, and T. Mann. 2009. Synthesis and characterization of a BODIPY-labeled derivative of Soraphen A that binds to acetyl-CoA carboxylase. Bioorg. Med. Chem. Lett. 19: 2804-2807.
32. Daitoku, H., K. Yamagata, H. Matsuzaki, M. Hatta, and A. Fukamizu. 2003. Regulation of PGC-1 promoter activity by protein kinase B and the forkhead transcription factor FKHR. Diabetes. 52: 642-649.
33. Matsuzaki, H., H. Daitoku, M. Hatta, K. Tanaka, and A. Fukamizu. 2003. Insulin-induced phosphorylation of FKHR (FoxO1) targets to proteasomal degradation. Proc. Natl. Acad. Sci. U.S.A. 100: 11285-11290.
34. Du, K., S. Herzig, R. N. Kulkarni, and M. Montminy. 2003. TRB3: a tribbles homolog that inhibits Akt/PKB activation by insulin in liver. Science. 300: 1574-1577.
35. Maira, S. M., I. Galetic, D. P. Brazil, S. Kaech, E. Ingley, M. Thelen, and B. A. Hemmings. 2001. Carboxyl-terminal modulator protein (CTMP), a negative regulator of PKB/Akt and v-Akt at the plasma membrane. Science. 294: 374-380.
36. Ugi, S., T. Imamura, H. Maegawa, K. Egawa, T. Yoshizaki, K. Shi, T. Obata, Y. Ebina, A. Kashiwagi, and J. M. Olefsky. 2004. Protein phosphatase 2A negatively regulates insulin's metabolic signaling pathway by inhibiting Akt (protein kinase B) activity in 3T3L1 adipocytes. Mol. Cell. Biol. 24: 8778-8789.
37. Yan, L., V. A. Lavin, L. R. Moser, Q. Cui, C. Kanies, and E. Yang. 2008. PP2A regulates the pro-apoptotic activity of FOXO1. J. Biol. Chem. 283: 7411-7420.
38. Chen, J., B. L. Martin, and D. L. Brautigan. 1992. Regulation of protein serine-threonine phosphatase type-2A by tyrosine phosphorylation. Science. 257: 1261-1264.
39. Zhou, Y., L. Li, Q. Liu, G. Xing, X. Kuai, J. Sun, X. Yin, J. Wang, L. Zhang, and F. He. 2008. E3 ubiquitin ligase SIAH1 mediates ubiquitination and degradation of TRB3. Cell. Signal. 20: 942-948.
40. Pawar, A., and D. B. Jump. 2003. Unsaturated fatty acid regulation of peroxisome proliferator-activated receptor alpha activity in rat primary hepatocytes. J. Biol. Chem. 278: 35931-35939.
41. Jump, D. B. 2002. The biochemistry of n-3 polyunsaturated fatty acids. J. Biol. Chem. 277: 8755-8758.
42. Stulnig, T. M., J. Huber, N. Leitinger, E. M. Imre, P. Angelisova, P. Nowotny, and W. Waldhausl. 2001. Polyunsaturated eicosapentaenoic acid displaces proteins from membrane rafts by altering raft lipid composition. J. Biol. Chem. 276: 37335-37340.
43. Chen, W., D. B. Jump, W. J. Esselman, and J. V. Busik. 2007. Inhibition of cytokine signaling in human retinal endothelial cells through modification of caveolae/lipid rafts by docosahexaenoic acid. Invest. Ophthalmol. Vis. Sci. 48: 18-26.
44. Chen, W., W. J. Esselman, D. B. Jump, and J. V. Busik. 2005. Antiinfl ammatory effect of docosahexaenoic acid on cytokine-induced adhesion molecule expression in human retinal vascular endothelial cells. Invest. Ophthalmol. Vis. Sci. 46: 4342-4347.
45. Chen, W., D. B. Jump, M. B. Grant, W. J. Esselman, and J. V. Busik. 2003. Dyslipidemia, but not hyperglycemia, induces inflammatory adhesion molecules in human retinal vascular endothelial cells. Invest. Ophthalmol. Vis. Sci. 44: 5016-5022.
46. Tikhonenko, M., T. Lydic, Y. Wang, W. Chen, M. Opreanu, A. Sochacki, K. M. McSorley, R. L. Renis, T. Kern, D. B. Jump, et al. 2010. Remodeling of retinal fatty acids in an animal model of diabetes. A decrease in long chain PUFA is associated with a decrease in fatty acid elongases Elovl2 and Elovl4. Diabetes. 59: 219-227.
47. Abu-Elheiga, L., M. M. Matzuk, P. Kordari, W. Oh, T. Shaikenov, Z. Gu, and S. J. Wakil. 2005. Mutant mice lacking acetyl-CoA carboxylase 1 are embryonically lethal. Proc. Natl. Acad. Sci. USA. 102: 12011-12016.
48. Sakamoto, K., A. McCarthy, D. Smith, K. A. Green, D. Grahame Hardie, A. Ashworth, and D. R. Alessi. 2005. Deficiency of LKB1 in skeletal muscle prevents AMPK activation and glucose uptake during contraction. EMBO J. 24: 1810-1820.
49. Samuel, V. T., S. A. Beddow, T. Iwasaki, X. M. Zhang, X. Chu, C. D. Still, G. S. Gerhard, and G. I. Shulman. 2009. Fasting hyperglycemia is not associated with increased expression of PEPCK or G6Pc in patients with Type 2 Diabetes. Proc. Natl. Acad. Sci. USA. 106: 12121-12126.
50. Burgess, S. C., T. He, Z. Yan, J. Lindner, A. D. Sherry, C. R. Malloy, J. D. Browning, and M. A. Magnuson. 2007. Cytosolic phosphoenolpyruvate carboxykinase does not solely control the rate of hepatic gluconeogenesis in the intact mouse liver. Cell Metab. 5: 313-320.
51. Chevalier, S., S. C. Burgess, C. R. Malloy, R. Gougeon, E. B. Marliss, and J. A. Morais. 2006. The greater contribution of gluconeogenesis to glucose production in obesity is related to increased wholebody protein catabolism. Diabetes. 55: 675-681.
52. Kamagate, A., S. Qu, G. Perdomo, D. Su, D. H. Kim, S. Slusher, M. Meseck, and H. H. Dong. 2008. FoxO1 mediates insulin-dependent regulation of hepatic VLDL production in mice. J. Clin. Invest. 118: 2347-2364.
53. Altomonte, J., L. Cong, S. Harbaran, A. Richter, J. Xu, M. Meseck, and H. H. Dong. 2004. Foxo1 mediates insulin action on apoC-III and triglyceride metabolism. J. Clin. Invest. 114: 1493-1503.
54. Jump, D. B. 2009. Mammalian fatty acid elongases. Methods Mol. Biol. 579: 375-389.